Search results
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
FOX 4 Kansas City· 1 week agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 weeks agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 1 week agoKeytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...
Merck beats earnings forecasts as cancer drug sales boom
Crain's New York Business· 1 week agoThe guidance comes as Merck’s first-quarter earnings topped $15.8 billion, a 9% increase from the...
Analysts Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $251.70
ETF DAILY NEWS· 2 weeks agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports ...
BeiGene (NASDAQ:BGNE) Trading Down 2.4%
ETF DAILY NEWS· 2 weeks agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report)’s stock price dropped 2.4% during trading on Friday . The company traded as low as $126.97 and last traded at $128.77. Approximately 17,319 shares ...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 1 week agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...